THE NEXT FRONTIER IN PARKINSONS-DISEASE - PRESYMPTOMATIC DETECTION

被引:41
作者
LANGSTON, JW [1 ]
KOLLER, WC [1 ]
机构
[1] UNIV KANSAS,MED CTR,DEPT NEUROL,KANSAS CITY,KS 66103
关键词
D O I
10.1212/WNL.41.5_Suppl_2.5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:5 / 7
页数:3
相关论文
共 5 条
[1]   INCREASED LIFE EXPECTANCY RESULTING FROM ADDITION OF L-DEPRENYL TO MADOPAR TREATMENT IN PARKINSONS-DISEASE - A LONGTERM STUDY [J].
BIRKMAYER, W ;
KNOLL, J ;
RIEDERER, P ;
YOUDIM, MBH ;
HARS, V ;
MARTON, J .
JOURNAL OF NEURAL TRANSMISSION, 1985, 64 (02) :113-127
[2]   POSITRON EMISSION TOMOGRAPHY AFTER MPTP - OBSERVATIONS RELATING TO THE CAUSE OF PARKINSONS-DISEASE [J].
CALNE, DB ;
LANGSTON, JW ;
MARTIN, WRW ;
STOESSL, AJ ;
RUTH, TJ ;
ADAM, MJ ;
PATE, BD ;
SCHULZER, M .
NATURE, 1985, 317 (6034) :246-248
[3]  
LANGSTON JW, 1990, NEUROLOGY, V40, P61
[4]   THE EFFECT OF DEPRENYL (SELEGILINE) ON THE NATURAL-HISTORY OF PARKINSONS-DISEASE [J].
TETRUD, JW ;
LANGSTON, JW .
SCIENCE, 1989, 245 (4917) :519-522
[5]  
1989, NEW ENGL J MED, V321, P1364